Details for 2018765254

Up to date per 01.04.2026

Actions

Title / Product Name

KONDENSIERTE HETEROCYCLISCHE DERIVATE ALS BCL-2-INHIBITOREN ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018765254

EP Publication Number

3672975

E-Number

1559736

Language

PCT Number

US18047411

Publication Date

01.07.2020 A

12.04.2023 B1

Registration Date

12.04.2023

AT Publication Date

15.05.2023

Application Date

22.08.2018

Registration Number

Priorities

23.08.2017

201762549081 P

09.01.2018

201862615007 P

IPC

C07D 498/14 20060101AFI20190301BHEP

Maximum Duration of Protection

22.08.2038

Owner

Guangzhou Lupeng Pharmaceutical Company Ltd.Room 322, Building B Shilian Science Park No. 33 Science Avenue Huangpu District, Guangzhou City GuangDong ProvinceCN

Representative

No representatives present

Inventor

CHEN, Yi3447 Gravina Place Pleasanton, CA 94566US

LOU, Yan4973 Monaco Drive Pleasanton, CA 94566US